<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="prolidase-def" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">prolidase-def</book-part-id>
      <title-group>
        <title>Prolidase Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ferreira</surname>
            <given-names>Carlos</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>National Human Genome Research Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>carlos.ferreira@nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Heng</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>DDC Clinic for Special Needs Children<break/>Middlefield, Ohio</aff>
          <email>wang@ddcclinic.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2015-06-25" date-type="created">
          <day>25</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ppr-dysp" document-type="chapter">Progressive Pseudorheumatoid Dysplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pomc-def" document-type="chapter">Proopiomelanocortin Deficiency</related-object>
      <abstract id="prolidase-def.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Prolidase deficiency is characterized by skin lesions (typically severe, chronic, recalcitrant, and painful skin ulcers of the lower extremities and telangiectasias of the face and hands), recurrent infections (particularly of the skin and respiratory tract), dysmorphic facial features, variable intellectual disability, and hepatomegaly with elevated liver enzymes and splenomegaly. Anemia, thrombocytopenia, hypergammaglobulinemia, and hypocomplementemia are common. An association between systemic lupus erythematosus (SLE) and prolidase deficiency has been described.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of prolidase deficiency is established by detection of either biallelic <italic toggle="yes">PEPD</italic> pathogenic variants or reduced prolidase enzyme activity in a proband who has characteristic clinical findings and imidodipeptiduria.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> No curative treatment is available. Supportive treatment of skin, lung, and immunologic manifestations has been efficacious in some (but not in all) patients. Caution is warranted in the treatment of infections, which can be fulminant and fatal. Developmental and educational interventions as needed to address motor and cognitive delays.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Those who have undergone splenectomy should be appropriately immunized and treated promptly with antibiotics at the first sign of infection. Antibiotic prophylaxis should also be considered in the appropriate setting.</p>
          <p><italic toggle="yes">Surveillance:</italic> In the absence of formal surveillance guidelines, the authors recommend annual: skin examination for evidence of malignant transformation in persons with chronic recalcitrant skin ulcers, complete blood count, liver function tests, and abdominal ultrasound examination to assess the size of the liver and spleen. Follow up as recommended by a pulmonologist and immunologist. Follow-up assessments of motor and cognitive development as recommended for educational planning.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> In those with splenomegaly: avoid contact sports given the increased risk for splenic rupture.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Prolidase deficiency is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <italic toggle="yes">PEPD</italic> pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="prolidase-def.Diagnosis">
        <title>Diagnosis</title>
        <p>No formal diagnostic criteria or testing algorithms for prolidase deficiency have been published.</p>
        <sec id="prolidase-def.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Prolidase deficiency <bold>should be suspected</bold> in individuals with the following clinical, laboratory, and biochemical findings.</p>
          <p>
            <bold>Clinical</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Skin lesions, typically lower extremity ulcers. Other lesions such as telangiectasias of the face and hands are also common [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.dunn.2011.194">Dunn et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>Recurrent infections, particularly of the skin and respiratory tract [<xref ref-type="bibr" rid="prolidase-def.REF.cleary.1994.345">Cleary et al 1994</xref>]</p>
            </list-item>
            <list-item>
              <p>Chronic lung disease with digital clubbing and a cystic fibrosis-like phenotype [<xref ref-type="bibr" rid="prolidase-def.REF.luder.2007.656">Luder et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Dysmorphic facial features, including widely spaced eyes, proptosis, depressed nasal bridge, prognathism, thin vermilion of the upper lip, and low anterior and posterior hairline [<xref ref-type="bibr" rid="prolidase-def.REF.goodman.1968.152">Goodman et al 1968</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.dunn.2011.194">Dunn et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Developmental delay of variable degree [<xref ref-type="bibr" rid="prolidase-def.REF.hechtman.2001">Hechtman 2001</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.lupi.2008.739">Lupi et al 2008</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.besio.2015.53">Besio et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p>Splenomegaly [<xref ref-type="bibr" rid="prolidase-def.REF.nasser.2015.169">Nasser et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p>Systemic lupus erythematosus-like phenotype [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.klar.2010.727">Klar et al 2010</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>]</p>
            </list-item>
          </list>
          <p><bold>Laboratory.</bold> Frequent, although not universal, laboratory findings include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Anemia, usually mild (hemoglobin &#x0003e;10 g/dL), but occasionally below that value [<xref ref-type="bibr" rid="prolidase-def.REF.powell.1974.505">Powell et al 1974</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.moulonguet.1989.792">Moulonguet et al 1989</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.cleary.1994.345">Cleary et al 1994</xref>]</p>
            </list-item>
            <list-item>
              <p>Thrombocytopenia, usually mild (&#x0003e;100,000 platelets per &#x003bc;L), although rarely it can be lower [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>]</p>
            </list-item>
            <list-item>
              <p>Elevated liver enzymes, with elevation of aspartate aminotransferase in the 100s [<xref ref-type="bibr" rid="prolidase-def.REF.sekiya.1985.125">Sekiya et al 1985</xref>]</p>
            </list-item>
            <list-item>
              <p>Hypergammaglobulinemia, mainly elevation of IgG and IgA, although occasionally also elevation of IgM. Reference ranges for immunoglobulins are age dependent, but upper limits of normal at any age are: IgG ~1600 mg/dL, IgA 350 mg/dL, and IgM 280 mg/dL.</p>
              <list list-type="bullet">
                <list-item>
                  <p>IgG levels &#x0003e;2,000 mg/dL have been reported numerous times [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.gray.1983.143">Gray et al 1983</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.lopes.2002.140">Lopes et al 2002</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</xref>] and as high as 3,680 mg/dL [<xref ref-type="bibr" rid="prolidase-def.REF.klar.2010.727">Klar et al 2010</xref>].</p>
                </list-item>
                <list-item>
                  <p>IgA levels &#x0003e;500 mg/dL have been reported on several occasions [<xref ref-type="bibr" rid="prolidase-def.REF.gray.1983.143">Gray et al 1983</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.lopes.2002.140">Lopes et al 2002</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>] and as high as 850 mg/dL [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>].</p>
                </list-item>
                <list-item>
                  <p>IgM concentrations as high as 568 mg/dL have been described [<xref ref-type="bibr" rid="prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Hypocomplementemia. Levels of C3 ranging from 30 to 74 mg/dL (normal: 75-175 mg/dL) have been published [<xref ref-type="bibr" rid="prolidase-def.REF.klar.2010.727">Klar et al 2010</xref>], with C4 as low as 9 mg/dL (normal: 20-40 mg/dL) [<xref ref-type="bibr" rid="prolidase-def.REF.cleary.1994.345">Cleary et al 1994</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</xref>].</p>
            </list-item>
          </list>
          <p><bold>Biochemical.</bold> Prolidase deficiency is characterized by massive imidodipeptiduria* (10-30 mmol/day) on urine amino acid analysis [<xref ref-type="bibr" rid="prolidase-def.REF.hechtman.2001">Hechtman 2001</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>In individuals with prolidase deficiency imidodipeptiduria has been detected as early as in the newborn period, even in the absence of signs or symptoms of the disease. (This finding has been used as the basis for urinary newborn screening in Quebec [<xref ref-type="bibr" rid="prolidase-def.REF.lemieux.1984.145">Lemieux et al 1984</xref>].)</p>
            </list-item>
            <list-item>
              <p>Under normal circumstances the urinary excretion of glycylproline is negligible [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>]; thus, the absence of detectable imidodipeptiduria in properly processed samples is sufficient evidence to rule out a diagnosis of prolidase deficiency [<xref ref-type="bibr" rid="prolidase-def.REF.freij.1986.431">Freij &#x00026; Der Kaloustian 1986</xref>].</p>
            </list-item>
          </list>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prolidase-def-detect-imidodipeptiduria.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for information on laboratory methods used to detect imidodipeptiduria.</p>
          <p>Other biochemical findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>The concentration of imidodipeptides is much lower in serum than urine [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Gly-Pro has been reported in the plasma by some investigators [<xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>], but not others [<xref ref-type="bibr" rid="prolidase-def.REF.hechtman.2001">Hechtman 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>CSF amino acid analysis was normal in the first report of probable prolidase deficiency [<xref ref-type="bibr" rid="prolidase-def.REF.goodman.1968.152">Goodman et al 1968</xref>].</p>
            </list-item>
          </list>
          <p>*Note: A number of published reports mistakenly refer to imidodipeptiduria as &#x02018;iminodipeptiduria.&#x02019; Iminodipeptides are dipeptides in which proline or hydroxyproline is the N-terminal amino acid (i.e., Pro/Hyp-X, for example prolylglycine), whereas imidodipeptides are dipeptides in which proline or hydroxyproline is the C-terminal amino acid (i.e., X-Pro/Hyp, for example glycylproline).</p>
        </sec>
        <sec id="prolidase-def.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of prolidase deficiency <bold>is established</bold> in a proband (who has the characteristic clinical findings and imidodipeptiduria) by detection of either biallelic <italic toggle="yes">PEPD</italic> pathogenic variants (see <xref ref-type="table" rid="prolidase-def.T.summary_of_molecular_gen">Table 2</xref>) or reduced prolidase enzyme activity.</p>
          <p><bold>Molecular genetic testing</bold> approaches include <bold>single gene testing</bold> and <bold>targeted analysis for pathogenic variants</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> For most individuals, sequence analysis of <italic toggle="yes">PEPD</italic> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>Targeted analysis for pathogenic variants.</bold> For Amish from Geauga County, Ohio and Druze and Arab Muslims from northern Israel, testing for the founder variants <xref ref-type="table" rid="prolidase-def.T.pepd_pathogenic_variants">p.Arg265Ter</xref> and <xref ref-type="table" rid="prolidase-def.T.pepd_pathogenic_variants">p.Ser202Phe</xref>, respectively, may be performed first followed by sequence analysis and gene-targeted deletion/duplication analysis if one or no pathogenic variant is identified.</p>
            </list-item>
          </list>
          <table-wrap id="prolidase-def.T.summary_of_molecular_gen" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Prolidase Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variants Detected</th>
                  <th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">PEPD</italic>
                  </td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">28/30&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">2/30&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" rowspan="2" valign="middle" colspan="1" align="left" scope="row">Targeted analysis for pathogenic variants</td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="prolidase-def.T.pepd_pathogenic_variants">p.Arg265Ter</xref>
                  </td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">4/4&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">
                    <xref ref-type="table" rid="prolidase-def.T.pepd_pathogenic_variants">p.Ser202Phe</xref>
                  </td>
                  <td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">17/20&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="prolidase-def.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="prolidase-def" object-id="prolidase-def.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="prolidase-def.TF.2.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="prolidase-def.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="prolidase-def.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="prolidase-def.TF.2.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="prolidase-def.REF.lupi.2008.739">Lupi et al [2008]</xref>
                </p>
              </fn>
              <fn id="prolidase-def.TF.2.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="prolidase-def.TF.2.6">
                <label>6. </label>
                <p>Amish from Geauga County, Ohio [<xref ref-type="bibr" rid="prolidase-def.REF.wang.2006.580">Wang et al 2006</xref>]</p>
              </fn>
              <fn id="prolidase-def.TF.2.7">
                <label>7. </label>
                <p>Druze and Arab Muslims from northern Israel [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>]</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Measurement of prolidase enzyme activity.</bold> In affected individuals, prolidase enzyme activity in erythrocytes, leukocytes, or cultured fibroblasts ranges from none to &#x0003c;10% [<xref ref-type="bibr" rid="prolidase-def.REF.lupi.2008.739">Lupi et al 2008</xref>].</p>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prolidase-def-diagnosis.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for a short review of laboratory techniques used in the diagnosis of prolidase deficiency; see also <xref ref-type="bibr" rid="prolidase-def.REF.kurien.2006.165">Kurien et al [2006]</xref> and <xref ref-type="bibr" rid="prolidase-def.REF.viglio.2006.1">Viglio et al [2006]</xref>.</p>
        </sec>
      </sec>
      <sec id="prolidase-def.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="prolidase-def.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Skin.</bold> The hallmark of prolidase deficiency is severe, chronic, recalcitrant, and painful skin ulcers. The ulcers are located mainly on the lower extremities, particularly the feet. However, individuals are reported with upper extremity involvement, including one with recurrent upper extremity ulceration beginning at age nine years [<xref ref-type="bibr" rid="prolidase-def.REF.sheffield.1977.578">Sheffield et al 1977</xref>], one with active ulcers on the hands [<xref ref-type="bibr" rid="prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</xref>], and one with a healed scar from prior ulcers in the dorsum of the hand [<xref ref-type="bibr" rid="prolidase-def.REF.eldarouti.2013">El-Darouti 2013</xref>]. One had scarring from healed ulcers over most of her body; however, at the time of publication active ulcers were mainly on the legs [<xref ref-type="bibr" rid="prolidase-def.REF.wysocki.1988.161">Wysocki et al 1988</xref>].</p>
          <p>Skin ulcers can begin as early as age six months [<xref ref-type="bibr" rid="prolidase-def.REF.mandel.2000.927">Mandel et al 2000</xref>] or as late as age 30 years [<xref ref-type="bibr" rid="prolidase-def.REF.dyne.2001.635">Dyne et al 2001</xref>].</p>
          <p>Ulceration is recurrent, and individual ulcers can take months to heal.</p>
          <p>Typically, no precipitating factors are identified with the appearance of an ulcer, although trauma has been reported as a triggering factor in at least two individuals [<xref ref-type="bibr" rid="prolidase-def.REF.gray.1983.143">Gray et al 1983</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>]. See <xref ref-type="fig" rid="prolidase-def.F1">Figure 1</xref>.</p>
          <p>A variety of skin findings can precede the appearance of ulcers by many years [<xref ref-type="bibr" rid="prolidase-def.REF.hechtman.2001">Hechtman 2001</xref>]. In the first 20 patients reported [<xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>], eight had telangiectasias of the face, shoulders, and hands; five had scaly, erythematous, maculopapular lesions; and two had purpuric lesions in the absence of hematologic abnormalities. In addition, five had premature graying of the hair.</p>
          <p>Occasional findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Lymphedema [<xref ref-type="bibr" rid="prolidase-def.REF.sheffield.1977.578">Sheffield et al 1977</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.dunn.2011.194">Dunn et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Hyperkeratosis of the elbows and knees [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>]</p>
            </list-item>
            <list-item>
              <p>Hirsutism [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>]</p>
            </list-item>
            <list-item>
              <p>Perioral pitted scars [<xref ref-type="bibr" rid="prolidase-def.REF.dunn.2011.194">Dunn et al 2011</xref>] or radial scars [<xref ref-type="bibr" rid="prolidase-def.REF.tiller.1977.20">Tiller 1977</xref>]</p>
            </list-item>
          </list>
          <p>As prolidase deficiency is associated with chronic recalcitrant lower extremity ulcers, an increased risk of squamous cell carcinoma of the skin could be expected, and indeed has been reported in one individual [<xref ref-type="bibr" rid="prolidase-def.REF.fimiani.1999.362">Fimiani et al 1999</xref>].</p>
          <p><bold>Dysmorphic facial features.</bold> Although not a universal finding, facial features typically described include prominent forehead, widely spaced eyes, proptosis, depressed nasal bridge, prognathism, thin vermilion of the upper lip, and low anterior and posterior hairlines [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.besio.2015.53">Besio et al 2015</xref>]. See <xref ref-type="fig" rid="prolidase-def.F2">Figure 2</xref>.</p>
          <p><bold>Neurologic manifestations.</bold> Intellectual disability of variable degree has been described in approximately 75% of individuals with prolidase deficiency [<xref ref-type="bibr" rid="prolidase-def.REF.hechtman.2001">Hechtman 2001</xref>]. <xref ref-type="table" rid="prolidase-def.T.iq_scores_reported_in_in">Table 3</xref> summarizes IQ scores reported in the medical literature to date.</p>
          <list list-type="bullet">
            <list-item>
              <p>In a review 12 of 30 individuals with molecularly confirmed prolidase deficiency had intellectual disability [<xref ref-type="bibr" rid="prolidase-def.REF.lupi.2008.739">Lupi et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>In a case series of 12 individuals with prolidase deficiency, one had speech delay, two had mild developmental delay, and six had intellectual disability; three had no delays [<xref ref-type="bibr" rid="prolidase-def.REF.besio.2015.53">Besio et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>In a case series of 20 Druze and Arab Muslims with prolidase deficiency living in northern Israel all had some degree of developmental delay, mainly moderate cognitive or speech delay [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>]. More specifically, two had speech delay, eight had mild developmental delay, five had moderate delay, and three had severe delay.</p>
            </list-item>
          </list>
          <table-wrap id="prolidase-def.T.iq_scores_reported_in_in" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p>IQ Scores Reported in Individuals with Prolidase Deficiency</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">IQ Score</th>
                  <th id="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Test Used</th>
                  <th id="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" scope="col" rowspan="1" colspan="1">Reference</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">30</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">NR</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.arata.1979.62">Arata et al [1979]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">48</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">NR</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al [1981]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">52</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">WISC-R</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al [1984]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">52</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">NR</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.sekiya.1985.125">Sekiya et al [1985]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">55</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">WISC-R</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.monafo.2000.227">Monafo et al [2000]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">61</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">WISC-R</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.tiller.1977.20">Tiller [1977]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">66</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">NR</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.cleary.1994.345">Cleary et al [1994]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">74</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">WISC-R</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.dunn.2011.194">Dunn et al [2011]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">85</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">WISC-R</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.powell.1974.505">Powell et al [1974]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">87</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">Peabody Picture Vocabulary Test, Form B</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.powell.1977.242">Powell et al [1977]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">80-90</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">NR</td>
                  <td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="prolidase-def.REF.goodman.1968.152">Goodman et al [1968]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>NR = not reported</p>
              </fn>
              <fn>
                <p>WISC-R = Wechsler Intelligence Scale for Children &#x02013; Revised</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Microcephaly was described in five of 11 individuals [<xref ref-type="bibr" rid="prolidase-def.REF.besio.2015.53">Besio et al 2015</xref>].</p>
          <p>Seizures have been described in rare cases [<xref ref-type="bibr" rid="prolidase-def.REF.de_rijcke.1989.309">De Rijcke et al 1989</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.wang.2006.580">Wang et al 2006</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>].</p>
          <p>Brain MRI findings include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Multiple microthromboses bilaterally in the cerebral white matter [<xref ref-type="bibr" rid="prolidase-def.REF.arata.1991.124">Arata et al 1991</xref>]</p>
            </list-item>
            <list-item>
              <p>Multiple bilateral subcortical white matter lesions (mainly in the parieto-occipital area), accompanied by leptomeningeal enhancement (one affected individual) [<xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Findings compatible with vasculitis [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Normal (one affected individual) [<xref ref-type="bibr" rid="prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</xref>]</p>
            </list-item>
          </list>
          <p>On nerve conduction studies one affected individual had decreased amplitude of motor action potentials and sensory action potentials [<xref ref-type="bibr" rid="prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</xref>].</p>
          <p><bold>Organomegaly.</bold> Hepatomegaly and splenomegaly are common [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>] and variable in severity; in one instance massive splenomegaly (spleen measuring 35 cm) has been reported [<xref ref-type="bibr" rid="prolidase-def.REF.nasser.2015.169">Nasser et al 2015</xref>].</p>
          <p>Liver enzymes may be mildly elevated [<xref ref-type="bibr" rid="prolidase-def.REF.wang.2006.580">Wang et al 2006</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>].</p>
          <p><bold>Hematologic manifestations.</bold> Anemia can be either mild microcytic hypochromic anemia [<xref ref-type="bibr" rid="prolidase-def.REF.powell.1974.505">Powell et al 1974</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.powell.1977.242">Powell et al 1977</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.pedersen.1983.785">Pedersen et al 1983</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.milligan.1989.405">Milligan et al 1989</xref>] or normocytic normochromic anemia [<xref ref-type="bibr" rid="prolidase-def.REF.dunn.2011.194">Dunn et al 2011</xref>].</p>
          <p>Hemolysis has been described [<xref ref-type="bibr" rid="prolidase-def.REF.lapiere.1969.353">Lapiere &#x00026; Nusgens 1969</xref>], with reticulocytosis varying from 5.9% [<xref ref-type="bibr" rid="prolidase-def.REF.powell.1977.242">Powell et al 1977</xref>] to 8.6% [<xref ref-type="bibr" rid="prolidase-def.REF.powell.1974.505">Powell et al 1974</xref>].</p>
          <p>Thrombocytopenia is fairly common [<xref ref-type="bibr" rid="prolidase-def.REF.powell.1974.505">Powell et al 1974</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.kavala.2006.24">Kavala et al 2006</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.wang.2006.580">Wang et al 2006</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>].</p>
          <p><bold>Immunologic manifestations.</bold> Recurrent episodes of otitis media, sinusitis, pneumonia, and gastroenteritis are common [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>].</p>
          <p>Elevated levels of IgG, IgA and IgM, and hypocomplementemia have been reported [<xref ref-type="bibr" rid="prolidase-def.REF.cleary.1994.345">Cleary et al 1994</xref>], as has decreased neutrophil chemotaxis [<xref ref-type="bibr" rid="prolidase-def.REF.cleary.1994.345">Cleary et al 1994</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.lopes.2002.140">Lopes et al 2002</xref>]. Serum levels of C1q have been normal [<xref ref-type="bibr" rid="prolidase-def.REF.gray.1983.143">Gray et al 1983</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.kurien.2013.674">Kurien et al 2013</xref>].</p>
          <p>Increased serum IgE levels have been reported [<xref ref-type="bibr" rid="prolidase-def.REF.di_rocco.2007.814">Di Rocco et al 2007</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.klar.2010.727">Klar et al 2010</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="prolidase-def.REF.martins.2000.75">Martins et al [2000]</xref> reported a patient with an IgE level of 20,000 IU/mL, which was as high as 77,600 IU/mL on follow up, with a Grimbacher score of 34 [<xref ref-type="bibr" rid="prolidase-def.REF.lopes.2002.140">Lopes et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="prolidase-def.REF.fukumura.2009.150">Fukumura et al [2009]</xref> reported an individual with a level of 23,000 IU/mL.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="prolidase-def.REF.hershkovitz.2006.435">Hershkovitz et al [2006]</xref> reported a patient with levels of 1,000-2,000 IU/mL with a Grimbacher score of 41, suggestive of autosomal dominant hyper IgE syndrome.</p>
            </list-item>
          </list>
          <p><bold>Pulmonary manifestations.</bold> Asthma-like chronic reactive airway disease was described in three of four Amish individuals with prolidase deficiency [<xref ref-type="bibr" rid="prolidase-def.REF.wang.2006.580">Wang et al 2006</xref>].</p>
          <p>Bronchiectasis, chronic lipoid pneumonia, and a cystic fibrosis phenotype including elevated sweat chloride and transepithelial potential difference has been described [<xref ref-type="bibr" rid="prolidase-def.REF.luder.2007.656">Luder et al 2007</xref>].</p>
          <p>One male developed severe progressive restrictive lung disease at age 45 years [<xref ref-type="bibr" rid="prolidase-def.REF.luder.2007.656">Luder et al 2007</xref>].</p>
          <p>A Druze woman age 24 years had progressive lung disease with chest CT findings of mainly cystic lung lesions and ground glass opacity [<xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>]. She experienced further deterioration in her pulmonary function and secondary pulmonary hypertension, and became oxygen dependent.</p>
          <p>An Amish boy age six years with pulmonary hypertension required supplemental oxygen [<xref ref-type="bibr" rid="prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</xref>].</p>
          <p><bold>Systemic lupus erythematosus-like findings.</bold> An association between systemic lupus erythematosus (SLE) and prolidase deficiency has been described in at least ten individuals, including three of 23 individuals from northern Israel [<xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</xref>].</p>
          <p>This association, first described by <xref ref-type="bibr" rid="prolidase-def.REF.bissonnette.1993.818">Bissonnette et al [1993]</xref> in a female age 16 years, included Raynaud&#x02019;s phenomenon, photosensitivity, arthritis, nephritis (with segmental mesangial deposits of IgA, IgM, and C3), antinuclear antibodies 1:650, and a positive rheumatoid factor.</p>
          <p><xref ref-type="bibr" rid="prolidase-def.REF.shrinath.1997.441">Shrinath et al [1997]</xref> reported two cousins with prolidase deficiency and SLE:</p>
          <list list-type="bullet">
            <list-item>
              <p>One had a malar facial rash, joint swellings, thrombocytopenia, neutropenia, proteinuria, pericarditis, hypocomplementemia, positive antinuclear antibody test (ANA), and strongly positive anti-dsDNA;</p>
            </list-item>
            <list-item>
              <p>The other had recurrent mouth ulcers, a malar rash, thrombocytopenia, neutropenia, positive ANA, positive anti-dsDNA, and positive pANCA.</p>
            </list-item>
          </list>
          <p>A boy age 11 years had photosensitivity, malar erythema, and a positive ANA of 1:40 [<xref ref-type="bibr" rid="prolidase-def.REF.cabrera.2004.684">Cabrera et al 2004</xref>].</p>
          <p>A boy age six years diagnosed with SLE was treated for two years with steroids and azathioprine, with amelioration of the immunologic abnormalities but worsening of the skin lesions [<xref ref-type="bibr" rid="prolidase-def.REF.lupi.2004.500">Lupi et al 2004</xref>].</p>
          <p>A male age 25 years had bilateral and symmetric synovitis affecting hands, elbows, and knees, a positive rheumatoid factor (516 IU/mL) and homogeneous ANA (1:640), and low C4 and CH50 (0.07 g/L and 61%) [<xref ref-type="bibr" rid="prolidase-def.REF.marotte.2010.88">Marotte et al 2010</xref>]. He fulfilled the American College of Rheumatology (ACR) criteria for rheumatoid arthritis and SLE (rhupus). Although he was diagnosed with prolidase deficiency based on increased imidodipeptiduria, prolidase enzymatic activity was not measured and <italic toggle="yes">PEPD</italic> sequencing was not performed. This patient did have increased bone turnover, a known cause of imidodipeptiduria in the absence of prolidase deficiency.</p>
          <p>An Amish boy age 2.5 years with fever of unknown etiology had urinalysis with 2+ proteinuria and hypoalbuminemia, ANA of 1:1080 with speckled pattern, and a positive anti-dsDNA [<xref ref-type="bibr" rid="prolidase-def.REF.d_souza.2006">D&#x02019;Souza et al 2006</xref>].</p>
          <p>Of two sibs reported by <xref ref-type="bibr" rid="prolidase-def.REF.klar.2010.727">Klar et al [2010]</xref>:</p>
          <list list-type="bullet">
            <list-item>
              <p>A girl age eight years had Raynaud&#x02019;s phenomenon, a positive ANA (1:1280; homogenous pattern), a positive anti ds-DNA &#x0003e;1:160, positive anti-ENA, anti-RNP and anti-Smith;</p>
            </list-item>
            <list-item>
              <p>Her brother, age 12 years, had Raynaud&#x02019;s phenomenon, a positive ANA (1:40; homogeneous) and anti ds-DNA (1.6 &#x003bc;g/mL), and low C3 (30-74 mg/dL).</p>
            </list-item>
          </list>
          <p>An individual with positive ANA and anti-dsDNA titers, as well as low complement levels had no hematologic, renal, or articular problems; although he was given a diagnosis of SLE, he did not fulfill ACR diagnostic criteria [<xref ref-type="bibr" rid="prolidase-def.REF.di_rocco.2007.814">Di Rocco et al 2007</xref>].</p>
          <p><xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al [2010]</xref> reported two individuals:</p>
          <list list-type="bullet">
            <list-item>
              <p>One with Coombs-positive hemolytic anemia, severe medication-resistant thrombocytopenia which required splenectomy, high levels of ANA and anti-cardiolipin antibodies, and a strongly positive anti-dsDNA;</p>
            </list-item>
            <list-item>
              <p>One with aphthous stomatitis, macroscopic hematuria and proteinuria eventually leading to renal failure (with a renal biopsy compatible with lupus nephritis), seizures, pancytopenia, Coombs-positive hemolytic anemia, hypocomplementemia, and elevated ANA and anti-dsDNA antibodies).</p>
            </list-item>
          </list>
          <p><xref ref-type="bibr" rid="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al [2012]</xref> reported three individuals with the SLE/prolidase deficiency association:</p>
          <list list-type="bullet">
            <list-item>
              <p>A boy age 4.5 years with a rash consistent with hypertrophic discoid lupus on biopsy, proteinuria and mild hematuria with a renal biopsy consistent with WHO Class IV lupus nephritis, low C3 and C4 levels, positive ANA (1:640; homogeneous pattern), anti ds-DNA, anti-RNP, anti-SM, anti Ro (SS-A) and anti La (SS-B)</p>
            </list-item>
            <list-item>
              <p>A girl age 16 years with macroscopic hematuria and proteinuria, with a renal biopsy demonstrating WHO Class IV lupus nephritis; she had low C3 and C4, as well as a highly positive ANA and positive anti ds-DNA titer</p>
            </list-item>
            <list-item>
              <p>A woman age 24 years with thrombocytopenia, a positive Coombs test, low C3 and C3 levels, and positive ANA and anti ds-DNA titers</p>
            </list-item>
          </list>
          <p>Positive ANA, anti-dsDNA, anti-ENA (anti-Ro), anti-Sm and anti-chromatin have been found in individuals with prolidase deficiency even in the absence of clinical findings of SLE [Kurien el al 2013].</p>
          <p><bold>Bone manifestations.</bold> Among 12 affected individuals reported by <xref ref-type="bibr" rid="prolidase-def.REF.besio.2015.53">Besio et al [2015]</xref>, short stature was described in seven, osteopenia in six, and genu valgum in four.</p>
          <p>Other bone findings include spina bifida of C3 and 13 thoracic vertebrae [<xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>]; fusion of C2 and C3 [<xref ref-type="bibr" rid="prolidase-def.REF.lacarbonara.2014.224">Lacarbonara et al 2014</xref>]; and delayed bone age [<xref ref-type="bibr" rid="prolidase-def.REF.pedersen.1983.785">Pedersen at al 1983</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.lacarbonara.2014.224">Lacarbonara et al 2014</xref>].</p>
          <p>Digital clubbing, in the presence and in the absence of pulmonary abnormalities, has also been reported [<xref ref-type="bibr" rid="prolidase-def.REF.luder.2007.656">Luder et al 2007</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</xref>].</p>
          <p>
            <bold>Other manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Joint laxity [<xref ref-type="bibr" rid="prolidase-def.REF.pasquali_ronchetti.1991.439">Pasquali Ronchetti et al 1991</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.lombeck.1986.571">Lombeck et al 1986</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.kavala.2006.24">Kavala et al 2006</xref>], including hip dislocation [<xref ref-type="bibr" rid="prolidase-def.REF.arata.1979.62">Arata et al 1979</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>]</p>
            </list-item>
            <list-item>
              <p>Protuberant abdomen in five of the first 17 cases reported [<xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>]</p>
            </list-item>
            <list-item>
              <p>Obesity [<xref ref-type="bibr" rid="prolidase-def.REF.andry.1992.818">Andry et al 1992</xref>]</p>
            </list-item>
            <list-item>
              <p>Optic and chorioretinal atrophy [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>], keratitis [<xref ref-type="bibr" rid="prolidase-def.REF.ogata.1981.689">Ogata et al 1981</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.freij.1984.561">Freij et al 1984</xref>] and pathologic myopia [<xref ref-type="bibr" rid="prolidase-def.REF.kiratli.1998.49">Kiratli &#x00026; Satilmi&#x0015f; 1998</xref>]</p>
            </list-item>
            <list-item>
              <p>Erosive cystitis (one individual) [<xref ref-type="bibr" rid="prolidase-def.REF.milligan.1989.405">Milligan et al 1989</xref>]</p>
            </list-item>
            <list-item>
              <p>Dental dysplasia [<xref ref-type="bibr" rid="prolidase-def.REF.moulonguet.1989.792">Moulonguet et al 1989</xref>]</p>
            </list-item>
            <list-item>
              <p>Autoimmune adrenal failure (one individual) [<xref ref-type="bibr" rid="prolidase-def.REF.luder.2007.656">Luder et al 2007</xref>]</p>
            </list-item>
          </list>
          <p><bold>Prognosis.</bold> The severity of prolidase deficiency is quite variable: in some individuals skin ulcerations lead to amputation of one [<xref ref-type="bibr" rid="prolidase-def.REF.lupi.2006.e58">Lupi et al 2006</xref>] or all toes [<xref ref-type="bibr" rid="prolidase-def.REF.sekiya.1985.125">Sekiya et al 1985</xref>], whereas others remain entirely asymptomatic.</p>
          <p>Two individuals diagnosed through systematic urinary newborn screening in Quebec [<xref ref-type="bibr" rid="prolidase-def.REF.lemieux.1984.145">Lemieux et al 1984</xref>] remained asymptomatic 14 years later [<xref ref-type="bibr" rid="prolidase-def.REF.hechtman.2001">Hechtman 2001</xref>].</p>
          <p>A man age 26 years, whose younger sister was affected, had imidodipeptiduria and prolidase deficiency in erythrocytes but no clinical manifestations [<xref ref-type="bibr" rid="prolidase-def.REF.isemura.1979.401">Isemura et al 1979</xref>].</p>
          <p>A woman age 29 years, the sister of an affected individual, had absence of prolidase activity in serum or erythrocytes, but no skin ulcers or other clinical manifestations of prolidase deficiency [<xref ref-type="bibr" rid="prolidase-def.REF.lupi.2006.e58">Lupi et al 2006</xref>].</p>
          <p>In most instances, individuals with prolidase deficiency experience severe morbidity and early death, usually due to infection.</p>
          <p>The individual with probable prolidase deficiency reported by <xref ref-type="bibr" rid="prolidase-def.REF.goodman.1968.152">Goodman et al [1968]</xref> had died of influenza by the time of a follow-up biochemical report four years later [<xref ref-type="bibr" rid="prolidase-def.REF.buist.1972.1113">Buist et al 1972</xref>]. He was about age 50 years at the time of death [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>].</p>
          <p>The female reported by <xref ref-type="bibr" rid="prolidase-def.REF.lapiere.1969.353">Lapiere &#x00026; Nusgens [1969]</xref> died at age 36 years [<xref ref-type="bibr" rid="prolidase-def.REF.endo.1990.162">Endo et al 1990</xref>]; she had superinfection of skin ulcers with <italic toggle="yes">Pseudomonas aeruginosa</italic>, which lead to septic shock and disseminated intravascular coagulation [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>].</p>
          <p>A female died of a fungal infection and disseminated intravascular coagulation [<xref ref-type="bibr" rid="prolidase-def.REF.sekiya.1985.125">Sekiya et al 1985</xref>].</p>
          <p>A girl age 16 years with prolidase deficiency and SLE developed cellulitis of the leg, followed by adult respiratory distress syndrome and death [<xref ref-type="bibr" rid="prolidase-def.REF.bissonnette.1993.818">Bissonnette et al 1993</xref>].</p>
          <p>A male died at 15 years of age of unknown reasons [<xref ref-type="bibr" rid="prolidase-def.REF.endo.1990.162">Endo et al 1990</xref>].</p>
          <p>A patient age 15 years died of terminal liver failure and cardiac failure [<xref ref-type="bibr" rid="prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</xref>].</p>
          <p>A patent age 11 years died of unknown causes [<xref ref-type="bibr" rid="prolidase-def.REF.besio.2015.53">Besio et al [2015]</xref>.</p>
          <p>A boy age eight years with prolidase deficiency and SLE died after developing a facial abscess and septicemia [<xref ref-type="bibr" rid="prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</xref>].</p>
          <p>The youngest reported death was at age four years [<xref ref-type="bibr" rid="prolidase-def.REF.mandel.2000.927">Mandel et al 2000</xref>].</p>
        </sec>
        <sec id="prolidase-def.GenotypePhenotype_Correlat">
          <title>Genotype-Phenotype Correlations</title>
          <p>There are no known genotype-phenotype correlations. Marked phenotypic variability has been found among affected individuals from the same family (who have the same pathogenic variants) [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>].</p>
        </sec>
        <sec id="prolidase-def.Nomenclature">
          <title>Nomenclature</title>
          <p>Prolidase deficiency was also known as hyperimidodipeptiduria, although increased excretion of imidodipeptides is not exclusive to prolidase deficiency. Other names used in the past include imidodipeptidase deficiency and peptidase D deficiency.</p>
        </sec>
        <sec id="prolidase-def.Prevalence">
          <title>Prevalence</title>
          <p>Approximately 90 affected individuals have been reported in the literature; however, prolidase deficiency likely remains underdiagnosed as a result of under-recognition by physicians.</p>
          <p>The Qu&#x000e9;bec Newborn Urine Screening Program (Programme qu&#x000e9;b&#x000e9;cois de d&#x000e9;pistage neonatal Urinaire, PQDNU) identified two affected infants out of 2,469,929 screened between 1973 and 2006, for an incidence of 1:1,235,000 [<xref ref-type="bibr" rid="prolidase-def.REF.renaud.2009">Renaud &#x00026; Dagenais 2009</xref>]. Thus, a few thousand cases would be predicted to exist worldwide, as opposed to only 90 cases reported to date.</p>
          <p>Prolidase deficiency has been diagnosed throughout the world [<xref ref-type="bibr" rid="prolidase-def.REF.lupi.2008.739">Lupi et al 2008</xref>].</p>
          <p>A founder variant has been described in the Geauga County settlement in Ohio [<xref ref-type="bibr" rid="prolidase-def.REF.wang.2006.580">Wang et al 2006</xref>], as well as in the Druze population in northern Israel, the latter with a carrier frequency of 1:21 [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2008.903">Falik-Zaccai et al 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="prolidase-def.Genetically_Related_Alleli">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">PEPD</italic>.</p>
      </sec>
      <sec id="prolidase-def.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <sec id="prolidase-def.Disorders_with_Imidodipept">
          <title>Disorders with Imidodipeptiduria</title>
          <p>Imidodipeptiduria has been described in bone disorders, presumably originating from collagen under conditions of high bone turnover.</p>
          <p>Glycylproline has been found in the urine of:</p>
          <list list-type="bullet">
            <list-item>
              <p>A child with severe bone disease and hyperphosphatasia [<xref ref-type="bibr" rid="prolidase-def.REF.seakins.1963.215">Seakins 1963</xref>];</p>
            </list-item>
            <list-item>
              <p>Two sisters with multiple fractures and striking bone deformities of unknown etiology [<xref ref-type="bibr" rid="prolidase-def.REF.alderman.1969.692">Alderman et al 1969</xref>];</p>
            </list-item>
            <list-item>
              <p>A woman age 28 years with osteomalacia and severe hyperparathyroidism who excreted large amounts of glycylproline, equivalent to ~1 g/day [<xref ref-type="bibr" rid="prolidase-def.REF.cahill.1970.519">Cahill et al 1970</xref>];</p>
            </list-item>
            <list-item>
              <p>Three individuals with rickets [<xref ref-type="bibr" rid="prolidase-def.REF.scriver.1964.357">Scriver 1964</xref>] who excreted decreasing amounts of glycylproline concomitant with clinical improvement, until the imidodipeptiduria disappeared with recovery from the disease.</p>
            </list-item>
          </list>
        </sec>
        <sec id="prolidase-def.Disorders_with_Skin_Ulcers">
          <title>Disorders with Skin Ulcers</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="werner" document-type="chapter">Werner syndrome</related-object> is characterized by cancer predisposition and the premature appearance of features associated with normal aging. Findings shared by prolidase deficiency and Werner syndrome are chronic lower extremity ulcers [<xref ref-type="bibr" rid="prolidase-def.REF.sternberg.1982.293">Sternberg et al 1982</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.yeong.2004.86">Yeong &#x00026; Yang 2004</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.noda.2011.e54">Noda et al 2011</xref>], premature graying of the hair, and a &#x0201c;bird-like&#x0201d; facial appearance [<xref ref-type="bibr" rid="prolidase-def.REF.milligan.1989.405">Milligan et al 1989</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.pasquali_ronchetti.1991.439">Pasquali Ronchetti et al 1991</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.zanaboni.1994.13">Zanaboni et al 1994</xref>]. Imidodipeptiduria has not been reported in Werner syndrome. Werner syndrome is caused by biallelic pathogenic variants in <italic toggle="yes">WRN</italic> and inherited in an autosomal recessive manner.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="sickle" document-type="chapter">Sickle cell disease</related-object> (SCD) is characterized by intermittent vaso-occlusive events and chronic hemolytic anemia. Leg ulcers which are relatively common in SCD were found in 2.5% of patients from the Cooperative Study of Sickle Cell Disease in the US [<xref ref-type="bibr" rid="prolidase-def.REF.koshy.1989.1403">Koshy et al 1989</xref>], in 43% in the Jamaican Cohort Study [<xref ref-type="bibr" rid="prolidase-def.REF.clare.2002.567">Clare et al 2002</xref>], and in 1.7% [<xref ref-type="bibr" rid="prolidase-def.REF.akinyanju.1979.87">Akinyanju &#x00026; Akinsete 1979</xref>] to 13.2% [<xref ref-type="bibr" rid="prolidase-def.REF.knoxmacaulay.1983.411">Knox-Macaulay 1983</xref>] of Africans.</p>
          <p>Although urinary excretion of hydroxyproline has been shown to be significantly increased in persons with sickle cell disease compared to controls [<xref ref-type="bibr" rid="prolidase-def.REF.mohammed.1991.285">Mohammed et al 1991</xref>] (presumably due to bone involvement), glycylprolinuria has not been reported in SCD. More importantly, although individuals with prolidase deficiency can have mild findings of hemolysis, they do not have veno-occlusive episodes. SCD is caused by biallelic pathogenic variants in <italic toggle="yes">HBB</italic> and inherited in an autosomal recessive manner.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="b-thal" document-type="chapter">Beta-thalassemia</related-object> is characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in reduced amounts of hemoglobin A, microcytic hypochromic anemia, and an abnormal peripheral blood smear with nucleated red blood cells. Affected individuals with other hemoglobinopathies such as &#x003b2;-thalassemia can also have chronic leg ulcers [<xref ref-type="bibr" rid="prolidase-def.REF.stevens.1977.1558">Stevens et al 1977</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.gimmon.1982.320">Gimmon et al 1982</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.levin.2011.316">Levin &#x00026; Koren 2011</xref>, <xref ref-type="bibr" rid="prolidase-def.REF.taher.2013">Taher et al 2013</xref>], but again no imidopeptiduria is known to occur. Persons with prolidase deficiency should have a normal hemoglobin electrophoretic pattern. &#x003b2;-thalassemia is caused by biallelic pathogenic variants in <italic toggle="yes">HBB</italic> and inherited in an autosomal recessive manner.</p>
          <p>Acquired causes of lower-extremity ulcers include arterial insufficiency, venous insufficiency, pressure ulcers, vasculitis, systemic lupus erythematosus, and infectious etiologies, among others. Although glycineprolinuria could be anticipated in cases of secondary skin ulcers given the high content of collagen in the dermis, a number of patients with extensive skin ulceration have been tested, and imidodipeptiduria was only found when accompanied by severe concurrent bone disease (e.g., multiple fractures) [<xref ref-type="bibr" rid="prolidase-def.REF.sheffield.1977.578">Sheffield et al 1977</xref>].</p>
        </sec>
        <sec id="prolidase-def.Disorders_with_Hyper_IgE">
          <title>Disorders with Hyper IgE</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="higes" document-type="chapter">Autosomal dominant hyper IgE syndrome</related-object> (AD-HIES) is a primary immune deficiency syndrome characterized by the classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum IgE. It is now recognized that other common manifestations include eczema, mucocutaneous candidiasis, and several connective tissue and skeletal abnormalities like osteopenia, minimal trauma fractures, and scoliosis. AD-HIES is caused by mutation of <italic toggle="yes">STAT3</italic>. A Grimbacher score of &#x0003e;40 is suggestive of AD-HIES.</p>
          <p>Autosomal recessive hyper IgE syndrome (AR-HIES) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/243700">OMIM</ext-link>) is a distinct clinical disorder, characterized by elevated serum concentration of IgE, severe eczema, and recurrent skin and lung infections [<xref ref-type="bibr" rid="prolidase-def.REF.renner.2004.93">Renner et al 2004</xref>], all of which can also be seen in prolidase deficiency. Prolidase deficiency differs from AD-HIES by an increased incidence of neurologic abnormalities, an increased occurrence of viral infections of the skin (e.g., <italic toggle="yes">Molluscum contagiosum</italic>, warts) and virus-driven malignancies, as well as absence of the non-immunologic findings of AD-HIES (e.g., connective tissue, skeletal and dental involvement) [<xref ref-type="bibr" rid="prolidase-def.REF.renner.2004.93">Renner et al 2004</xref>]. AR-HIES is caused by biallelic pathogenic variants in <italic toggle="yes">DOCK8.</italic></p>
        </sec>
      </sec>
      <sec id="prolidase-def.Management">
        <title>Management</title>
        <sec id="prolidase-def.Evaluations_Following_Init">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with prolidase deficiency, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Review of systems to assess for the possibility of pulmonary complications. In those with a history of pulmonary complications, consider chest imaging, pulmonary function tests, an echocardiogram to assess for pulmonary hypertension, and consultation with a pulmonologist.</p>
            </list-item>
            <list-item>
              <p>Physical examination to evaluate for splenomegaly. If present, perform an abdominal ultrasound examination to evaluate the extent of splenomegaly.</p>
            </list-item>
            <list-item>
              <p>Complete blood count to evaluate for anemia and thrombocytopenia</p>
            </list-item>
            <list-item>
              <p>Liver function tests to assess for the possibility of elevated liver enzymes</p>
            </list-item>
            <list-item>
              <p>Developmental assessment</p>
            </list-item>
            <list-item>
              <p>Consultation with a wound care specialist</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="prolidase-def.Treatment_of_Manifestation">
          <title>Treatment of Manifestations</title>
          <p>No curative treatment is available.</p>
          <p>Care is preferably provided by a multidisciplinary team. Supportive treatment of skin, lung, and immunologic manifestations has been efficacious in some (but not in all) patients. Caution is warranted in the treatment of infections, which can be fulminant and fatal.</p>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="prolidase-def-unsuccessful-treatments.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for further details, including treatments in which only partial or short-term benefit was reported.</p>
        </sec>
        <sec id="prolidase-def.Prevention_of_Secondary_Co">
          <title>Prevention of Secondary Complications</title>
          <p>Those who have undergone splenectomy should be appropriately immunized and treated promptly with antibiotics at the first sign of infection.</p>
          <p>Antibiotic prophylaxis should also be considered in the appropriate setting.</p>
        </sec>
        <sec id="prolidase-def.Surveillance">
          <title>Surveillance</title>
          <p>In the absence of formal surveillance guidelines, the authors recommend:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Skin examination for evidence of malignant transformation in persons with chronic recalcitrant skin ulcers</p>
                </list-item>
                <list-item>
                  <p>Complete blood count</p>
                </list-item>
                <list-item>
                  <p>Liver function tests</p>
                </list-item>
                <list-item>
                  <p>Abdominal ultrasound examination to assess liver and spleen size</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Follow up as recommended by a pulmonologist and immunologist;</p>
            </list-item>
            <list-item>
              <p>Follow-up assessments of motor and cognitive development as recommended for educational planning.</p>
            </list-item>
          </list>
        </sec>
        <sec id="prolidase-def.AgentsCircumstances_to_Avo">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with prolidase deficiency who have splenomegaly should avoid contact sports given the increased risk for splenic rupture.</p>
        </sec>
        <sec id="prolidase-def.Evaluation_of_Relatives_at">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="prolidase-def.Related_Genetic_Counseling">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="prolidase-def.Therapies_Under_Investigat">
          <title>Therapies Under Investigation</title>
          <p><bold>Adenovirus-mediated gene transfer.</bold>
<xref ref-type="bibr" rid="prolidase-def.REF.ikeda.1997.401">Ikeda et al [1997]</xref> performed transfer of the human prolidase cDNA into fibroblasts from patients with prolidase deficiency. This increased the fibroblast prolidase activity up to 75 times normal.</p>
          <p><bold>Intracellular delivery of liposome-encapsulated prolidase.</bold>
<xref ref-type="bibr" rid="prolidase-def.REF.perugini.2005.181">Perugini et al [2005]</xref> showed that active prolidase encapsulated in liposomes was completely transported via endocytosis into fibroblasts six days after incubation.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="prolidase-def.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="prolidase-def.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Prolidase deficiency is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="prolidase-def.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">PEPD</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with prolidase deficiency are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">PEPD</italic>.</p>
            </list-item>
            <list-item>
              <p>A high carrier rate for prolidase deficiency exists in certain populations, increasing the risk that an affected individual may have a reproductive partner who is heterozygous (see <xref ref-type="sec" rid="prolidase-def.Prevalence">Prevalence</xref>). The offspring of such an individual and a proband are at 50% risk of being affected and 50% risk of being obligate heterozygotes.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">PEPD</italic> pathogenic variant.</p>
        </sec>
        <sec id="prolidase-def.Carrier_Heterozygote_Detec">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">PEPD</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="prolidase-def.Related_Genetic_Counseling">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="prolidase-def.Prenatal_Testing_and_Preim">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">PEPD</italic> pathogenic variants have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for prolidase deficiency are possible options.</p>
          <p><bold>Biochemical genetic testing.</bold> Measurement of prolidase activity in amniocytes has been used for prenatal diagnosis [<xref ref-type="bibr" rid="prolidase-def.REF.mandel.2000.927">Mandel et al 2000</xref>]; however, molecular genetic testing is the preferred method if both <italic toggle="yes">PEPD</italic> pathogenic variants in an affected family member are known.</p>
          <p>Note: Results of prenatal testing cannot be used to predict age of onset or clinical course. Severity of the condition can vary among affected individuals within the same family.</p>
        </sec>
      </sec>
      <sec id="prolidase-def.Resources">
        <title>Resources</title>
      </sec>
      <sec id="prolidase-def.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">PEPD</italic> comprises 15 exons. There are three transcript variants, variant 1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000285.3">NM_000285.3</ext-link>) being the longest. Variants 2 and 3 lack two alternate in-frame exons in the central coding region, thus resulting in loss of an internal segment compared to isoform 1. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="prolidase-def" object-id="prolidase-def.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> More than 40 individuals with prolidase deficiency have been molecularly characterized. At least 22 different pathogenic variants have been reported to date.</p>
        <list list-type="bullet">
          <list-item>
            <p>The pathogenic variant p.Arg265Ter has been identified in all individuals of Amish heritage with prolidase deficiency from Geauga County, Ohio [Authors, personal observation].</p>
          </list-item>
          <list-item>
            <p>The pathogenic variant p.Ser202Phe is the most common pathogenic variant in Druze and Arab Muslim individuals from northern Israel. Of note, the pathogenic variant p.Ala212Pro was identified in one Arab Muslim family and the pathogenic variant p.Leu368Arg in one Druze family from the same region [<xref ref-type="bibr" rid="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</xref>].</p>
          </list-item>
        </list>
        <table-wrap id="prolidase-def.T.pepd_pathogenic_variants" position="anchor" orientation="portrait">
          <label>Table 4. </label>
          <caption>
            <p><italic toggle="yes">PEPD</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.605C&#x0003e;T</td>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser202Phe</td>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000285.3">NM_000285.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000276.2">NP_000276.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.634G&#x0003e;C</td>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala212Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.793C&#x0003e;T</td>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg265Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1103T&#x0003e;G</td>
                <td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu368Arg</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Prolidase contains 493 amino acids. It is a homodimer, with each subunit binding two manganese ions that are required for full enzymatic activity. The enzyme is required in the final catabolic steps of endogenous and dietary proteins, as it cleaves proline or hydroxyproline when these amino acids are in the C-terminal position. It is thus particularly important in the metabolism of proteins rich in proline and hydroxyproline, such as collagen.</p>
        <p><bold>Abnormal gene product.</bold> The deficiency of prolidase leads to accumulation of imidodipeptides, or peptides with two amino acids, with a C-terminal proline or hydroxyproline.</p>
      </sec>
      <sec id="prolidase-def.References">
        <title>References</title>
        <sec id="prolidase-def.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="prolidase-def.Literature_Cited.reflist0">
            <ref id="prolidase-def.REF.akinyanju.1979.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akinyanju</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akinsete</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Leg ulceration in sickle cell disease in Nigeria.</article-title>
                <source>Trop Geogr Med.</source>
                <year>1979</year>
                <volume>31</volume>
                <fpage>87</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">483376</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.alderman.1969.692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alderman</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frimpter</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheiner</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Glycylproline peptiduria in familial hyperostosis of obscure nature.</article-title>
                <source>Metabolism.</source>
                <year>1969</year>
                <volume>18</volume>
                <fpage>692</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">4895065</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.andry.1992.818">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodemer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teillac-Hamel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Prost</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Chronic leg ulcer in children with prolidase deficiency</article-title>
                <source>Ann Dermatol Venereol.</source>
                <year>1992</year>
                <volume>119</volume>
                <fpage>818</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">1301685</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.arata.1991.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tada</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oono</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasutomi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oka</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Angiopathic pathogenesis of clinical manifestations in prolidase deficiency.</article-title>
                <source>Arch Dermatol.</source>
                <year>1991</year>
                <volume>127</volume>
                <fpage>124</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">1986698</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.arata.1979.62">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umemura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nohara</surname>
                    <given-names>N.</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: its dermatological manifestations and some additional biochemical studies.</article-title>
                <source>Arch Dermatol.</source>
                <year>1979</year>
                <volume>115</volume>
                <fpage>62</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">760660</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.besio.2015.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Besio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gioia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallagher</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Lorenzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore-Barton</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deshpande</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydin</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokatli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwiek</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasapkara</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adisen</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurer</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phang</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunn</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Lack of prolidase causes a bone phenotype both in human and in mouse.</article-title>
                <source>Bone.</source>
                <year>2015</year>
                <volume>72</volume>
                <fpage>53</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">25460580</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.bissonnette.1993.818">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bissonnette</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giroux</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolenga</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hechtman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Der Kaloustian</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubuc</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: a multisystemic hereditary disorder.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>1993</year>
                <volume>29</volume>
                <fpage>818</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">8408817</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.buist.1972.1113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buist</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strandholm</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellinger</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennaway</surname>
                    <given-names>NG</given-names>
                  </name>
                </person-group>
                <article-title>Further studies on a patient with iminodipeptiduria: a probable case of prolidase deficiency.</article-title>
                <source>Metabolism.</source>
                <year>1972</year>
                <volume>21</volume>
                <fpage>1113</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">4674498</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.butbul_aviel.2012.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Butbul Aviel</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avitan Hersh</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adiv</surname>
                    <given-names>OE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brik</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency associated with systemic lupus erythematosus (SLE): single site experience and literature review.</article-title>
                <source>Pediatr Rheumatol Online J.</source>
                <year>2012</year>
                <volume>10</volume>
                <fpage>18</fpage>
                <pub-id pub-id-type="pmid">22726576</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.cabrera.2004.684">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cabrera</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giovanna</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozzini</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: case reports of two Argentinian brothers.</article-title>
                <source>Int J Dermatol.</source>
                <year>2004</year>
                <volume>43</volume>
                <fpage>684</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15357754</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.cahill.1970.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cahill</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westall</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <article-title>A detailed study of the urinary peptides in a patient with osteomalacia and hyperparathyroidism.</article-title>
                <source>Clin Sci.</source>
                <year>1970</year>
                <volume>38</volume>
                <fpage>519</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">5428813</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.cantatore.1993.410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cantatore</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannico</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrozzo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Chronic leg ulcerations resembling vasculitis in two siblings with prolidase deficiency.</article-title>
                <source>Clin Rheumatol.</source>
                <year>1993</year>
                <volume>12</volume>
                <fpage>410</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8258246</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.clare.2002.567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clare</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>FitzHenley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hambleton</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serjeant</surname>
                    <given-names>GR</given-names>
                  </name>
                </person-group>
                <article-title>Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence.</article-title>
                <source>Br J Haematol.</source>
                <year>2002</year>
                <volume>119</volume>
                <fpage>567</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12406102</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.cleary.1994.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cleary</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heaney</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couriel</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>Immune function in prolidase deficiency.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1994</year>
                <volume>17</volume>
                <fpage>345</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7807949</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.de_rijcke.1989.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Rijcke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Maubeuge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hariga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledoux</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency. Apropos of a peculiar case.</article-title>
                <source>Ann Dermatol Venereol.</source>
                <year>1989</year>
                <volume>116</volume>
                <fpage>309</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">2675733</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.di_rocco.2007.814">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fantasia</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martini</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2007</year>
                <volume>30</volume>
                <fpage>814</fpage>
                <pub-id pub-id-type="pmid">17570078</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.d_souza.2006">
              <mixed-citation publication-type="webpage">D&#x02019;Souza A, Kurien BT, Patel NC, Miller DL, Wang H, Scofield RH. Prolidase deficiency in systemic lupus erythematosus. Abstract 629. Washington, DC: American College of Rheumatology Annual Scientific Meeting; 2006. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://acr.confex.com/acr/2006/webprogram/Paper6124.html">online</ext-link>. Accessed 7-1-16</mixed-citation>
            </ref>
            <ref id="prolidase-def.REF.dunn.2011.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dunn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varigos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winship</surname>
                    <given-names>I.</given-names>
                  </name>
                </person-group>
                <article-title>A photographic essay of prolidase deficiency.</article-title>
                <source>Clin Dysmorphol.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>194</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21760498</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.dyne.2001.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dyne</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanaboni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertazzoni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viglio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iadarola</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Mild, late-onset prolidase deficiency: another Italian case.</article-title>
                <source>Br J Dermatol.</source>
                <year>2001</year>
                <volume>144</volume>
                <fpage>635</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11260036</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.eldarouti.2013">
              <mixed-citation publication-type="book">El-Darouti MA. Stubborn leg ulcers, stiff joints, acral sclerodermoid changes and fragile skin. In: <italic toggle="yes">Challenging Cases in Dermatology</italic>. London: Springer; 2013:113-7.</mixed-citation>
            </ref>
            <ref id="prolidase-def.REF.endo.1990.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanoue</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danks</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapi&#x000e8;re</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sei</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadman</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.</article-title>
                <source>J Clin Invest.</source>
                <year>1990</year>
                <volume>85</volume>
                <fpage>162</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">1688567</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.falikzaccai.2008.903">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kfir</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frenkel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shihab</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morkos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaref</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summar</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khayat</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Population screening in a Druze community: the challenge and the reward.</article-title>
                <source>Genet Med.</source>
                <year>2008</year>
                <volume>10</volume>
                <fpage>903</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19092443</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.falikzaccai.2010.46">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khayat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frenkel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brik</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershoni-Baruch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>A broad spectrum of developmental delay in a large cohort of prolidase deficiency patients demonstrates marked interfamilial and intrafamilial phenotypic variability.</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <year>2010</year>
                <volume>153B</volume>
                <fpage>46</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">19308961</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.fimiani.1999.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fimiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubegni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Aloe</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilenchi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreassi</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Squamous cell carcinoma of the leg in a patient with prolidase deficiency.</article-title>
                <source>Br J Dermatol.</source>
                <year>1999</year>
                <volume>140</volume>
                <fpage>362</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10233241</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.freij.1986.431">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freij</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Der Kaloustian</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency. A metabolic disorder presenting with dermatologic signs.</article-title>
                <source>Int J Dermatol</source>
                <year>1986</year>
                <volume>25</volume>
                <fpage>431</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">3771038</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.freij.1984.561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freij</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dudin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutasim</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deeb</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Der Kaloustian</surname>
                    <given-names>VM</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and biochemical characteristics of prolidase deficiency in siblings.</article-title>
                <source>Am J Med Genet.</source>
                <year>1984</year>
                <volume>19</volume>
                <fpage>561</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">6507502</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.fukumura.2009.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fukumura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasakura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doshita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoji</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchishima</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushima</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takase</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency with various clinical conditions including hyper-IgE and multiple lung bulla formation.</article-title>
                <source>Nihon Naika Gakkai Zasshi.</source>
                <year>2009</year>
                <volume>98</volume>
                <fpage>150</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19227921</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.gimmon.1982.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gimmon</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wexler</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rachmilewitz</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile leg ulceration in beta-thalassemia major and intermedia.</article-title>
                <source>Plast Reconstr Surg.</source>
                <year>1982</year>
                <volume>69</volume>
                <fpage>320</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7034014</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.goodman.1968.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>SI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomons</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muschenheim</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntyre</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>A syndrome resembling lathyrism associated with iminodipeptiduria.</article-title>
                <source>Am J Med.</source>
                <year>1968</year>
                <volume>45</volume>
                <fpage>152</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">4968882</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.gray.1983.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>RGF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peck</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Biochemical and immunological studies on a family with prolidase deficiency.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1983</year>
                <volume>6</volume>
                <fpage>143</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">6422153</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.hechtman.2001">
              <mixed-citation publication-type="book">Hechtman P. Prolidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. Chap 82. 8 ed. New York, NY: McGraw-Hill. 2001:1839-56.</mixed-citation>
            </ref>
            <ref id="prolidase-def.REF.hershkovitz.2006.435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hershkovitz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassoun</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Indelman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shlush</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollack</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A homozygous missense mutation in PEPD encoding peptidase D causes prolidase deficiency associated with hyper-IgE syndrome.</article-title>
                <source>Clin Exp Dermatol.</source>
                <year>2006</year>
                <volume>31</volume>
                <fpage>435</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">16681595</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.ikeda.1997.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tohyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oono</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuragawa</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Amelioration of prolidase deficiency in fibroblasts using adenovirus mediated gene transfer.</article-title>
                <source>Jpn J Hum Genet.</source>
                <year>1997</year>
                <volume>42</volume>
                <fpage>401</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12503186</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.isemura.1979.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Isemura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanyu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gejyo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency with imidodipeptiduria. A familial case with and without clinical symptoms.</article-title>
                <source>Clin Chim Acta.</source>
                <year>1979</year>
                <volume>93</volume>
                <fpage>401</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">445856</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.kavala.2006.24">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kavala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zindanci</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sudogan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turkoglu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarigul</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Ulcus cruris associated with prolidase deficiency.</article-title>
                <source>Dermatol Online J.</source>
                <year>2006</year>
                <volume>12</volume>
                <fpage>24</fpage>
                <pub-id pub-id-type="pmid">17459310</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.kelly.2010.1031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowen</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <article-title>An Amish boy with recurrent ulcerations of the lower extremities, telangiectases of the hands, and chronic lung disease.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2010</year>
                <volume>62</volume>
                <fpage>1031</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20466176</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.kiratli.1998.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kiratli</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satilmi&#x0015f;</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency associated with pathologic myopia.</article-title>
                <source>Ophthalmic Genet.</source>
                <year>1998</year>
                <volume>19</volume>
                <fpage>49</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">9587929</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.klar.2010.727">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navon-Elkan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubinow</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Branski</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurvitz</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khayat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: it looks like systemic lupus erythematosus but it is not.</article-title>
                <source>Eur J Pediatr.</source>
                <year>2010</year>
                <volume>169</volume>
                <fpage>727</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">19937054</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.knoxmacaulay.1983.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knox-Macaulay</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <article-title>Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults.</article-title>
                <source>Ann Trop Med Parasitol.</source>
                <year>1983</year>
                <volume>77</volume>
                <fpage>411</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">6639186</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.koshy.1989.1403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koshy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Entsuah</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koranda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellvue</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flournoy-Gill</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Leg ulcers in patients with sickle cell disease.</article-title>
                <source>Blood.</source>
                <year>1989</year>
                <volume>74</volume>
                <fpage>1403</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">2475188</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.kurien.2013.674">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurien</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Sousa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruner</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Targoff</surname>
                    <given-names>IN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier-Moore</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harley</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scofield</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency breaks tolerance to lupus-associated antigens.</article-title>
                <source>Int J Rheum Dis.</source>
                <year>2013</year>
                <volume>16</volume>
                <fpage>674</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">24330273</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.kurien.2006.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurien</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Souza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scofield</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency and the biochemical assays used in its diagnosis.</article-title>
                <source>Anal Biochem.</source>
                <year>2006</year>
                <volume>349</volume>
                <fpage>165</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">16298326</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lacarbonara.2014.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lacarbonara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazzolla</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacarbonara</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Venere</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capogreco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marzo</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: dento-facial aspects in a paediatric patient.</article-title>
                <source>Eur J Paediatr Dent.</source>
                <year>2014</year>
                <volume>15</volume>
                <fpage>224</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25101509</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lapiere.1969.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lapiere</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nusgens</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Torpid skin wounds and collagen metabolism disorder.</article-title>
                <source>Arch Belg Dermatol Syphiligr.</source>
                <year>1969</year>
                <volume>25</volume>
                <fpage>353</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">5401875</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lemieux.1984.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lemieux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auray-Blais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giguere</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapcott</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: detection of cases by a newborn urinary screening programme.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1984</year>
                <volume>7</volume>
                <fpage>145</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">6434873</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.levin.2011.316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koren</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy.</article-title>
                <source>Isr Med Assoc J.</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>316</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21845977</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lombeck.1986.571">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lombeck</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wendel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Versieck</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ballenberghe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bremer</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadman</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria).</article-title>
                <source>Eur J Pediatr.</source>
                <year>1986</year>
                <volume>144</volume>
                <fpage>571</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">3709569</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lopes.2002.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lopes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marques</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neves</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taveira</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency with hyperimmunoglobulin E: a case report.</article-title>
                <source>Pediatr Allergy Immunol.</source>
                <year>2002</year>
                <volume>13</volume>
                <fpage>140</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">12000488</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.luder.2007.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luder</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khayat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurevich</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frankel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivlin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falik-Zaccai</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <article-title>Chronic lung disease and cystic fibrosis phenotype in prolidase deficiency: a newly recognized association.</article-title>
                <source>J Pediatr.</source>
                <year>2007</year>
                <volume>150</volume>
                <fpage>656</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17517257</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lupi.2004.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lupi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Riso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torre</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship.</article-title>
                <source>J Hum Genet.</source>
                <year>2004</year>
                <volume>49</volume>
                <fpage>500</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15309682</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lupi.2006.e58">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lupi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pecora</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elcioglu</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gultepe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family.</article-title>
                <source>J Med Genet.</source>
                <year>2006</year>
                <volume>43</volume>
                <fpage>e58</fpage>
                <pub-id pub-id-type="pmid">17142620</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.lupi.2008.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lupi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations.</article-title>
                <source>Amino Acids.</source>
                <year>2008</year>
                <volume>35</volume>
                <fpage>739</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">18340504</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.mandel.2000.927">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeling</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berant</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholten</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheiman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gennip</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis.</article-title>
                <source>Prenat Diagn.</source>
                <year>2000</year>
                <volume>20</volume>
                <fpage>927</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11113899</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.marotte.2010.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marotte</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gineyts</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miossec</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: a rare aetiology of arthritis.</article-title>
                <source>Joint Bone Spine.</source>
                <year>2010</year>
                <volume>77</volume>
                <fpage>88</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20031465</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.martins.2000.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <collab>Society for the Study of Inborn Errors of Metabolism</collab>
                </person-group>
                <article-title>Prolidase deficiency associated to hyper IgE.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2000</year>
                <volume>23</volume>
                <fpage>75</fpage>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.milligan.1989.405">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milligan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham-Brown</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: a case report and literature review.</article-title>
                <source>Br J Dermatol.</source>
                <year>1989</year>
                <volume>121</volume>
                <fpage>405</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">2679858</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.mohammed.1991.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mohammed</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suleiman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Addae</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annobil</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adzaku</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kadoummi</surname>
                    <given-names>OF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <article-title>Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease.</article-title>
                <source>Clin Chim Acta.</source>
                <year>1991</year>
                <volume>203</volume>
                <fpage>285</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">1777988</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.monafo.2000.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monafo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marseglia</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maghnie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyne</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Transient beneficial effect of GH replacement therapy and topical GH application on skin ulcers in a boy with prolidase deficiency.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2000</year>
                <volume>17</volume>
                <fpage>227</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">10886759</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.moulonguet.1989.792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moulonguet</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamberger</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Larrard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myara</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchet-Bardon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markuch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Civatte</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Leg ulcers and prolidase deficiency.</article-title>
                <source>Ann Dermatol Venereol.</source>
                <year>1989</year>
                <volume>116</volume>
                <fpage>792</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">2619164</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.nasser.2015.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nasser</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajab</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanios</surname>
                    <given-names>BY</given-names>
                  </name>
                </person-group>
                <article-title>Massive splenomegaly secondary to prolidase deficiency.</article-title>
                <source>Am J Med Sci.</source>
                <year>2015</year>
                <volume>349</volume>
                <fpage>169</fpage>
                <pub-id pub-id-type="pmid">23811574</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.noda.2011.e54">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyagawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kogure</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamaki</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Bosentan: a novel therapy for leg ulcers in Werner syndrome.</article-title>
                <source>J Am Acad Dermatol.</source>
                <year>2011</year>
                <volume>65</volume>
                <fpage>e54</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21763553</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.ogata.1981.689">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomoda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikuchi</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive prolidase deficiency. Three patients with recalcitrant ulcers.</article-title>
                <source>Arch Dermatol.</source>
                <year>1981</year>
                <volume>117</volume>
                <fpage>689</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">7316526</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.pasquali_ronchetti.1991.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasquali Ronchetti</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaglino</surname>
                    <given-names>D</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Dyne</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanaboni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Ultrastructural studies on dermis from prolidase deficient subjects.</article-title>
                <source>J Submicrosc Cytol Pathol.</source>
                <year>1991</year>
                <volume>23</volume>
                <fpage>439</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">1913589</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.pedersen.1983.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandt</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency.</article-title>
                <source>Acta Paediatr Scand.</source>
                <year>1983</year>
                <volume>72</volume>
                <fpage>785</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6637477</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.perugini.2005.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perugini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modena</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavanetto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iadarola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients.</article-title>
                <source>J Control Release.</source>
                <year>2005</year>
                <volume>102</volume>
                <fpage>181</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">15653144</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.powell.1977.242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurosky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maniscalco</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: report of a second case with quantitation of the excessively excreted amino acids.</article-title>
                <source>J Pediatr.</source>
                <year>1977</year>
                <volume>91</volume>
                <fpage>242</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">874681</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.powell.1974.505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasco</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maniscalco</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>A prolidase deficiency in man with iminopeptiduria.</article-title>
                <source>Metabolism.</source>
                <year>1974</year>
                <volume>23</volume>
                <fpage>505</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">4828441</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.renaud.2009">
              <mixed-citation publication-type="book">Renaud J, Dagenais P. Agence d&#x02019;&#x000e9;valuation des technologies et des modes d&#x02019;intervention en sant&#x000e9;. La pertinence du d&#x000e9;pistage n&#x000e9;onatal urinaire des erreurs inn&#x000e9;es du m&#x000e9;tabolisme r&#x000e9;alis&#x000e9; au Qu&#x000e9;bec: rapport. Montr&#x000e9;al, Qu&#x000e9;bec: ETMIS. 2009.</mixed-citation>
            </ref>
            <ref id="prolidase-def.REF.renner.2004.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frosch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.</article-title>
                <source>J Pediatr.</source>
                <year>2004</year>
                <volume>144</volume>
                <fpage>93</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14722525</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.royce.2002">
              <mixed-citation publication-type="book">Royce P, Steinmann B. Prolidase deficiency. In: Royce P, Steinmann B, eds. <italic toggle="yes">Connective Tissue and Its Heritable Disorders</italic>. New York: Wiley-Liss; 2002:727-738.</mixed-citation>
            </ref>
            <ref id="prolidase-def.REF.scriver.1964.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scriver</surname>
                    <given-names>CR</given-names>
                  </name>
                </person-group>
                <article-title>Glycyl-proline in urine of humans with bone disease.</article-title>
                <source>Can J Physiol Pharmacol.</source>
                <year>1964</year>
                <volume>42</volume>
                <fpage>357</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">14324167</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.seakins.1963.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seakins</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Peptiduria in an unusual bone disorder. Isolation of two peptides.</article-title>
                <source>Arch Dis Child.</source>
                <year>1963</year>
                <volume>38</volume>
                <fpage>215</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">13987500</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.sekiya.1985.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sekiya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohnishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>An autopsy case of prolidase deficiency.</article-title>
                <source>Virchows Arch A Pathol Anat Histopathol.</source>
                <year>1985</year>
                <volume>406</volume>
                <fpage>125</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">3922107</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.sheffield.1977.578">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faull</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halpern</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schier</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotton</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammond</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danks</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Iminopeptiduria, skin ulcerations, and edema in a boy with prolidase deficiency.</article-title>
                <source>J Pediatr.</source>
                <year>1977</year>
                <volume>91</volume>
                <fpage>578</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">908977</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.shrinath.1997.441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shrinath</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haeney</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couriel</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrick</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency and systemic lupus erythematosus.</article-title>
                <source>Arch Dis Child.</source>
                <year>1997</year>
                <volume>76</volume>
                <fpage>441</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9196362</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.sternberg.1982.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Hur</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Werner's syndrome as a cause of chronic leg ulcers.</article-title>
                <source>J Dermatol Surg Oncol.</source>
                <year>1982</year>
                <volume>8</volume>
                <fpage>293</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7076970</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.stevens.1977.1558">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shupack</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javid</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silber</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Ulcers of the leg in thalassemia.</article-title>
                <source>Arch Dermatol.</source>
                <year>1977</year>
                <volume>113</volume>
                <fpage>1558</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">931395</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.taher.2013">
              <mixed-citation publication-type="webpage">Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Leg Ulcers: In: Weatherall D, ed. <italic toggle="yes">Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT).</italic> Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK190456/">online</ext-link>. 2013. Accessed 7-1-16.</mixed-citation>
            </ref>
            <ref id="prolidase-def.REF.tiller.1977.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tiller</surname>
                    <given-names>JWG</given-names>
                  </name>
                </person-group>
                <article-title>Psychiatric problems in a boy with prolidase deficiency.</article-title>
                <source>Aust J Ment Retard.</source>
                <year>1977</year>
                <volume>4</volume>
                <fpage>20</fpage>
                <lpage>1</lpage>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.viglio.2006.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Viglio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annovazzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perugini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casado</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iadarola</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>The role of emerging techniques in the investigation of prolidase deficiency: from diagnosis to the development of a possible therapeutical approach.</article-title>
                <source>J Chromatogr B Analyt Technol Biomed Life Sci.</source>
                <year>2006</year>
                <volume>832</volume>
                <fpage>1</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16434239</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.wang.2006.580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurien</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundgren</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Souza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nye</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tumbush</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hupertz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurono</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scofield</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>A nonsense mutation of PEPD in four Amish children with prolidase deficiency.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>580</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16470701</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.wysocki.1988.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wysocki</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panegyres</surname>
                    <given-names>PK</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: a patient without hydroxyproline-containing iminodipeptides in urine.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1988</year>
                <volume>11</volume>
                <fpage>161</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">3139928</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.yeong.2004.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yeong</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Chronic leg ulcers in Werner's syndrome.</article-title>
                <source>Br J Plast Surg.</source>
                <year>2004</year>
                <volume>57</volume>
                <fpage>86</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14672683</pub-id>
              </element-citation>
            </ref>
            <ref id="prolidase-def.REF.zanaboni.1994.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zanaboni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyne</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monafo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.</article-title>
                <source>Haematologica.</source>
                <year>1994</year>
                <volume>79</volume>
                <fpage>13</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15378943</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="prolidase-def.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="prolidase-def.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>25 June 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>20 January 2015 (cf) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="prolidase-def.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Typical skin ulcerations in individuals with prolidase deficiency.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="prolidase-def-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="prolidase-def.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Prominent forehead, proptosis, depressed nasal bridge, and thin vermilion of the upper lip can be appreciated.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="prolidase-def-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
